Clinical Trials Find here a list of clinical trials sorted under open and closed. Open Clinical Trials EU MDS Registry. A prospective, multicenter European Registry for newly diagnosed patients with Myelodysplastic Syndromes of IPSS low and intermediate-1 subtypes. (EU MDS Registry) EVI-3: Combining Active and Passive DNA Hypomethylation NMDSG14B: Individual molecular minimal residual disease monitoring for patients with MDS and mixed MDS/MPN treated with allogeneic stem cell transplantation Closed Clinical Trials NMDSG07A. A multicentre phase II study of the efficacy and safety of lenalidomide in high-risk myeloid disease (high-risk MDS and AML) with a karyotype including del(5q) or monosomy 5 (NMDSG07A). Published. NMDSG10A. A pilot phase I dose finding safety study of a Thrombopoietin-receptor agonist, Eltrombopag, in patients with Myelodysplastic syndrome treated with Azacitidine (NMDSG10A). Published.
